Switch to:
Boston Scientific Corporation (NYSE:BSX)
Cash Flow from Operations
$1,082 Mil (TTM As of Dec. 2013)

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2013, Boston Scientific Corporation's Net Income From Continuing Operations was $-121 Mil. Its DDA was $689 Mil. Its Change In Working Capital was $155 Mil. Its cash flow from deferred tax was $-223 Mil. Its Cash Flow from Discontinued Operations was $0 Mil. And its Cash Flow from Others was $-227 Mil. In all, Boston Scientific Corporation's Cash Flow from Operations for the three months ended in Dec. 2013 was $273 Mil.


Definition

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Boston Scientific Corporation's Cash Flow from Operations for the fiscal year that ended in Dec. 2013 is calculated as:

Boston Scientific Corporation's Cash Flow from Operations for the quarter that ended in Dec. 2013 is

Boston Scientific Corporation Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2013 was 163 (Mar. 2013 ) + 396 (Jun. 2013 ) + 250 (Sep. 2013 ) + 273 (Dec. 2013 ) = $1,082 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Boston Scientific Corporation's net income from continuing operations for the three months ended in Dec. 2013 was $-121 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
• The term “depreciation” is used when discussing man made tangible assets
• The term “depletion” is used when discussing natural tangible assets
• The term “amortization” is used when discussing intangible assets

Boston Scientific Corporation's depreciation, depletion and amortization for the three months ended in Dec. 2013 was $689 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Boston Scientific Corporation's change in working capital for the three months ended in Dec. 2013 was $155 Mil. It means Boston Scientific Corporation's working capital increased by $155 Mil from Sep. 2013 to Dec. 2013 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Boston Scientific Corporation's cash flow from deferred tax for the three months ended in Dec. 2013 was $-223 Mil.

5. Cash Flow from Discontinued Operations:
Cash received by a company that comes from the sale of part of business.

Boston Scientific Corporation's cash flow from discontinued operations for the three months ended in Dec. 2013 was $0 Mil.

6. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Boston Scientific Corporation's cash flow from others for the three months ended in Dec. 2013 was $-227 Mil.


Related Terms

Net Income From Continuing Operations, Depreciation, Depletion and Amortization, Change In Working Capital, Cash Flow from Discontinued Operations, Cash Flow from Others, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Boston Scientific Corporation Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
NetIncomeFromContinuingOperations 1,062628-3,577-495-2,036-1,025-1,065441-4,068-121
CF_DDA 275314781918864834816717683689
ChangeInWorkingCapital 173-36732347-77925-1,373-237284155
CF_DeferredTax 304-420-386-334-64-11046-166-223
Cash Flow from Disc. Op. 0000000000
Cash Flow from Others 2643244,7388502,7991652,057414,527582
Cash Flow from Operations 1,8049031,8459341,2168353251,0081,2601,082

Boston Scientific Corporation Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
NetIncomeFromContinuingOperations 0441000-4,068000-121
CF_DDA 0717000683000689
ChangeInWorkingCapital 0-237000284000155
CF_DeferredTax 046000-166000-223
Cash Flow from Disc. Op. 0000000000
Cash Flow from Others 366-6182124072723,636163396250-227
Cash Flow from Operations 366349212407272369163396250273
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide